UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046437
Receipt number R000052951
Scientific Title Impact of combined resection of the internal iliac artery on the loss of volume of the gluteus muscles after pelvic exenteration
Date of disclosure of the study information 2021/12/22
Last modified on 2021/12/22 13:19:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of pelvic exenteration on muscle volume

Acronym

Impact of pelvic exenteration on muscle volume

Scientific Title

Impact of combined resection of the internal iliac artery on the loss of volume of the gluteus muscles after pelvic exenteration

Scientific Title:Acronym

Impact of combined resection of the internal iliac artery on the loss of volume of the gluteus muscles after pelvic exenteration

Region

Japan


Condition

Condition

Pelvic malignancy

Classification by specialty

Surgery in general Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the impact of pelvic exenteration on muscle volume

Basic objectives2

Others

Basic objectives -Others

Assessment of invasiveness

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To clarify muscle volume change after surgery

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who underwent pelvic exenteration

Key exclusion criteria

Patients who couldn't assess by the CT imaging before and after surgery

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Kay
Middle name
Last name Uehara

Organization

Nagoya University Graduate School of Medicine

Division name

Division of Surgical Oncology, Department of Surgery

Zip code

4668550

Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-744-2222

Email

kuehara@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Yuki
Middle name
Last name Murata

Organization

Nagoya University Graduate School of Medicine

Division name

Division of Surgical Oncology, Department of Surgery

Zip code

4668550

Address

65 Tsurumai-cho, Showa-ku, Nagoya

TEL

052-744-2222

Homepage URL


Email

yukimura@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University

Institute

Department

Personal name



Funding Source

Organization

Nagoya University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Graduate School of Medicine

Address

65 Tsurumai-cho, Showa-ku, Nagoya

Tel

052-744-2973

Email

ethics@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

78

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 11 Month 01 Day

Date of IRB

2020 Year 06 Month 29 Day

Anticipated trial start date

2019 Year 12 Month 01 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We investigated muscle volume change after pelvic exenteration(PE) retrospectively. Areas of gluteal muscles and psoas muscles, common surrogate marker of sarcopenia, were calculated using CT images before and after PE, and the difference was compared.
In addition, this study aimed to clarify the influence of additional internal iliac artery (IIA) resection on the loss of the gluteus muscle volume after pelvic exenteration (PE).


Management information

Registered date

2021 Year 12 Month 22 Day

Last modified on

2021 Year 12 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052951